Testing for rheumatoid arthritis involves a combination of blood tests, a physical exam, and sometimes imaging. No single test confirms it on its own. Instead, doctors use a scoring system that adds up findings across several categories, and a score of 6 out of 10 or higher leads to a formal diagnosis. The process can usually begin with your primary care doctor, though you’ll likely be referred to a rheumatologist for confirmation.
What Happens at the First Appointment
A doctor will start by examining your joints. They’re looking for visible swelling, warmth, and tenderness, particularly in the small joints of your hands and feet. A quantitative joint count, where the doctor systematically presses on and inspects dozens of joints, is the most specific physical measure for identifying RA. In practice, many rheumatologists do a careful qualitative exam rather than a full formal count, but the goal is the same: mapping which joints are inflamed and whether the pattern is symmetric (affecting both sides of the body).
You’ll also be asked how long your symptoms have lasted. This matters for diagnosis. Symptoms lasting six weeks or longer earn an extra point in the scoring system, and that single point can be the difference between a confirmed diagnosis and a “wait and recheck” result.
Blood Tests Used to Diagnose RA
After the physical exam, your doctor will order blood work. No fasting is typically required. The key tests fall into two categories: antibody tests that look for immune markers specific to RA, and inflammation tests that measure how much systemic inflammation your body is producing.
Antibody Tests
The two main antibody tests are rheumatoid factor (RF) and anti-CCP (also called ACPA). Anti-CCP is the more reliable of the two. It has a specificity of about 95%, meaning that when it comes back positive, there’s a very high chance you actually have RA rather than something else. Rheumatoid factor is less precise, with a specificity around 85%, because it can show up in other conditions like infections or liver disease.
The sensitivity of these tests, their ability to catch RA when it’s truly present, is lower than most people expect. Anti-CCP is only positive in about 23% of people with very early RA. By the time of diagnosis, roughly half of patients test positive, and the number climbs to 53% to 70% two years later. So a negative result early on does not rule out RA. If your symptoms are convincing, your doctor may retest months later.
High-positive results on either test carry more diagnostic weight (3 points in the scoring system) than low-positive results (2 points).
Inflammation Markers
Two blood tests measure general inflammation: ESR (sed rate) and CRP (C-reactive protein). ESR normal ranges depend on age and sex, generally falling below 15 to 20 mm/hr for men and 20 to 30 mm/hr for women. CRP is normally below 1.0. If either comes back elevated, it adds 1 point toward your diagnosis. These tests aren’t specific to RA, since a cold or other infection can raise them, but in the context of joint swelling, they’re an important piece of the puzzle.
How the Scoring System Works
Doctors use a standardized system developed by the American College of Rheumatology and its European counterpart. It assigns points across four categories, and you need 6 out of 10 to be classified as having definite RA.
- Joint involvement (0 to 5 points): One large joint scores 0. Two to ten large joints scores 1. One to three small joints scores 2. Four to ten small joints scores 3. More than ten joints, with at least one small joint, scores the maximum 5.
- Serology (0 to 3 points): Negative RF and anti-CCP scores 0. A low positive on either scores 2. A high positive scores 3.
- Inflammation markers (0 to 1 point): Normal ESR and CRP scores 0. An abnormal result on either scores 1.
- Symptom duration (0 to 1 point): Under six weeks scores 0. Six weeks or longer scores 1.
A person who falls below 6 isn’t told they definitely don’t have RA. They may meet the threshold later as more joints become involved or antibody levels rise. The requirement also includes confirmed swelling in at least one joint and no better explanation for the symptoms.
When Imaging Is Needed
X-rays have traditionally been the go-to, but they have a significant blind spot: they can only show joint damage after it’s already happened and often miss early inflammation entirely. In early RA, MRI detects bone erosions in 45% to 72% of patients within the first six months of disease. X-rays catch only 8% to 40% in the same window.
MRI is considered the best non-invasive tool for evaluating joint inflammation. It can reveal swelling of the joint lining, tendon inflammation, and a finding called bone marrow edema, which is thought to be a precursor to the permanent erosions that show up later on X-rays. Ultrasound is another option that’s more accessible and less expensive than MRI. It’s also more sensitive than a physical exam alone for detecting joint inflammation, though it can’t visualize all erosions the way MRI can due to limitations in probe positioning.
Not everyone gets imaging right away. Your doctor may order it if blood tests are inconclusive, if they need to assess how much damage has already occurred, or if they want a baseline to compare against future scans.
What If Your Blood Tests Come Back Negative
About 20% to 30% of people with RA are “seronegative,” meaning they test negative for both rheumatoid factor and anti-CCP antibodies. This doesn’t mean they don’t have RA. Because the scoring system doesn’t require positive antibody tests, a person with widespread small joint involvement (5 points), elevated inflammation markers (1 point), and symptoms lasting six weeks or more (1 point) can reach the 6-point threshold with zero contribution from serology.
Seronegative RA is harder to diagnose and often takes longer to confirm. Imaging becomes especially important in these cases, since MRI or ultrasound findings can provide the objective evidence of joint inflammation that blood tests didn’t.
Conditions That Can Look Like RA
Part of the diagnostic process is ruling out other conditions that cause similar symptoms. The list is longer than most people realize: psoriatic arthritis, lupus, osteoarthritis, gout, fibromyalgia, ankylosing spondylitis, polymyalgia rheumatica, and several connective tissue diseases can all overlap with RA in their early stages. Your doctor may order additional blood tests targeting these conditions, such as checking uric acid levels (for gout) or antinuclear antibodies (for lupus). If a joint is especially swollen, a sample of fluid may be drawn with a needle and analyzed. In RA, joint fluid typically shows a white blood cell count between 2,000 and 50,000 per cubic millimeter, placing it in the inflammatory range.
Misdiagnosis is a recognized problem. If you’ve been diagnosed with RA but aren’t responding to treatment as expected, it’s reasonable to ask your doctor whether the diagnosis should be revisited.
Why Getting Tested Early Matters
RA causes the most joint damage in its earliest stages, often before people realize how serious it is. Research points to a treatment window in the first 12 weeks after symptoms begin as the period with the greatest potential to prevent permanent joint erosion. Older studies described a broader two-year window, but the trend in recent evidence is toward acting faster. Starting treatment within that early window is associated with better odds of achieving remission and avoiding the disability that comes from structural damage to bone and cartilage.
If you’re experiencing persistent joint swelling, particularly in the hands or feet and on both sides, lasting more than a few weeks, that’s enough to warrant blood work and a referral. The testing itself is straightforward: a physical exam, a few tubes of blood, and possibly an imaging study. The results can come together within days to weeks, and the earlier the process starts, the more options you have.

